In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination-Reference-Cited by-同舟云学术

In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination

Published:2017-05-08 Issue:5 Volume:11 Page:e0005584
ISSN:1935-2735
Container-title:PLOS Neglected Tropical Diseases
language:en
Short-container-title:PLoS Negl Trop Dis

Author:

Whitehead Stephen S.,Durbin Anna P.,Pierce Kristen K.,Elwood Dan,McElvany Benjamin D.,Fraser Ellen A.,Carmolli Marya P.,Tibery Cecilia M.,Hynes Noreen A.,Jo Matthew,Lovchik Janece M.,Larsson Catherine J.,Doty Elena A.,Dickson Dorothy M.,Luke Catherine J.,Subbarao Kanta,Diehl Sean A.^ORCID,Kirkpatrick Beth D.

Funder

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Publisher

Public Library of Science (PLoS)

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference45 articles.

1. Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Dengue Prevention Boards;ME Beatty;PLoS Negl Trop Dis,2010

2. (PAHO/WHO) PAHOWHO. Five-fold increase in dengue cases in the Americas over the past decade Washington, D.C.2014, May 29. Available from: http://www.paho.org/hq/index.php?option=com_content&view=article&id=9657&Itemid=1926.

3. The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus;MU Kraemer;Elife,2015

4. Dengue;CP Simmons;N Engl J Med,2012

5. Research on dengue during World War II;A Sabin;Am J Trop Med Hyg,1952

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An effective pan-serotype dengue vaccine and enhanced control strategies could help in reducing the severe dengue burden in Bangladesh–A perspective;Frontiers in Microbiology;2024-08-20

2. The Urgent Need for Dengue Vaccination: Combating an Escalating Public Health Crisis in Pakistan;Vaccines;2024-08-13

3. Efficacy and safety of Butantan-DV in participants aged 2–59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil;The Lancet Infectious Diseases;2024-08

4. Subgenomic flavivirus RNA as key target for live-attenuated vaccine development;Journal of Virology;2024-07-23

5. Regional Variation of the CD4 and CD8 T Cell Epitopes Conserved in Circulating Dengue Viruses and Shared with Potential Vaccine Candidates;Viruses;2024-05-05